<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48533">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01837628</url>
  </required_header>
  <id_info>
    <org_study_id>7/13</org_study_id>
    <nct_id>NCT01837628</nct_id>
  </id_info>
  <brief_title>Reducing Urethral Pain During Urodynamic Test - Comparison Between Lidocaine Gel and Paraffin Oil</brief_title>
  <official_title>Reducing Urethral Pain During Urodynamic Test - Comparison Between Lidocaine Gel and Paraffin Oil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our purpose is to compare between intraurethral lidocaine gel and paraffin oil in reducing
      urethral pain during urodynamic test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized into two groups: 1) Lidocaine Gel 2) Paraffin Oil. They will
      fill out 1 visual analogue scale (0-10) for urethral pain during the test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Analogue scale (0-10) for pain</measure>
    <time_frame>up to 1 hour after the procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>patients will fill ou the scale before, during and immediately after the test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Lidocaine gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraurethral Lidocaine gel 2%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paraffin Oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraurethral injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Gel</intervention_name>
    <arm_group_label>Lidocaine gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paraffin Oil</intervention_name>
    <arm_group_label>Paraffin Oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All men who will be referred for urodynamic test

        Exclusion Criteria:

          -  Active infection

          -  Permanent Catheter
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kobi Stav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf Harofe MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kobi Stav, MD</last_name>
    <email>stavkobi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assaf Harofe Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kobi Stav, MD</last_name>
      <email>stavkobi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kobi Stav, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 22, 2013</lastchanged_date>
  <firstreceived_date>April 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urodynamic</keyword>
  <keyword>Paraffin oil</keyword>
  <keyword>Lidocaine gel</keyword>
  <keyword>Pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
